文献速递神经MR

正常脑与脑肿瘤ADC:脉冲梯度自旋回波扩散成像中扩散时间和/或回波时间变化的影响

Normal Brain and Brain Tumor ADC: Changes Resulting From Variation of Diffusion Time and/or Echo Time in Pulsed-Gradient Spin Echo Diffusion Imaging.
PubMed 文献 · Invest Radiol · 2024-04-09

研究在高性能3T MRI上评估扩散时间和回波时间对ADC的影响,纳入10名健康志愿者和10名脑肿瘤患者,使用扩散时间16、40、70 ms,回波时间60、75、104 ms及3个b值。正常组织ADC变化较小,而扩散率高于1.0 μm²/ms的肿瘤在延长回波时间时ADC增加可达12%。

要点

  • 正常脑组织ADC随扩散时间和回波时间的变化幅度小,临床可忽略。
  • 扩散率高于1.0 μm²/ms的肿瘤在延长回波时间时ADC增加可达12%。
  • ADC作为定量生物标志物时需报告扩散时间与回波时间等时序参数。

核心结论

  • 在探索的参数范围内,正常组织ADC变化似乎可忽略;而肿瘤ADC变化在将ADC用作定量生物标志物时可能具有相关性,而非仅靠视觉评估。

研究设计与样本

  • 在3T MRI扫描仪上进行脉冲梯度自旋回波脑部扫描,纳入10名健康志愿者和10名脑肿瘤患者,扩散时间16、40、70 ms,回波时间60、75、104 ms,3个b值(0、100、1000 s/mm²),最大梯度幅度68 mT/m,并通过将扩散编码梯度幅度降至19 mT/m模拟低梯度性能系统。

关键影像表现/征象

  • 健康受试者在6个深部灰质区域和6个白质区域测量ADC,患者测量肿瘤实性部分ADC。
  • 随着扩散时间增加,6个聚合深部灰质结构ADC出现小但显著的增加,最高达2.5%。
  • 随着回波时间增加或梯度性能降低,6个聚合白质结构ADC出现小但显著的降低,最高达2.6%。
  • 肿瘤中扩散时间相关的ADC变化不一致,无明确趋势。
  • 扩散率高于1.0 μm²/ms的肿瘤在延长回波时间时ADC增加高达12%,而扩散率等于或低于1.0 μm²/ms的肿瘤无变化或降低;梯度性能降低时观察到相似结果,增加高达21%。

诊断标准与关键数值

  • 重复实验测定的变异系数为2.4%。
  • 肿瘤按扩散率高于1.0 μm²/ms与等于或低于1.0 μm²/ms分组,高扩散率组延长回波时间时ADC增加高达12%,低扩散率组无变化或降低。

临床应用与阅片要点

  • 在ADC研究中应报告所有相关时序参数;在构建多中心研究扫描方案时考虑扩散时间和回波时间的影响。
  • ADC作为定量生物标志物时需注意肿瘤ADC可随回波时间和梯度性能变化,不能仅依赖视觉评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Increasing gradient performance on modern magnetic resonance imaging scanners has profoundly reduced the attainable diffusion and echo times for clinically available pulsed-gradient spin echo (PGSE) sequences. This study investigated how this may impact the measured apparent diffusion coefficient (ADC), which is considered an important diagnostic marker for differentiation between normal and abnormal brain tissue and for therapeutic follow-up.

MATERIALS AND METHODS: Diffusion time and echo time dependence of the ADC were evaluated on a high-performance 3 T magnetic resonance imaging scanner. Diffusion PGSE brain scans were performed in 10 healthy volunteers and in 10 brain tumor patients using diffusion times of 16, 40, and 70 ms, echo times of 60, 75, and 104 ms at 3 b-values (0, 100, and 1000 s/mm 2 ), and a maximum gradient amplitude of 68 mT/m. A low gradient performance system was also emulated by reducing the diffusion encoding gradient amplitude to 19 mT/m. In healthy subjects, the ADC was measured in 6 deep gray matter regions and in 6 white matter regions. In patients, the ADC was measured in the solid part of the tumor.

RESULTS: With increasing diffusion time, a small but significant ADC increase of up to 2.5% was observed for 6 aggregate deep gray matter structures. With increasing echo time or reduced gradient performance, a small but significant ADC decrease of up to 2.6% was observed for 6 aggregate white matter structures. In tumors, diffusion time-related ADC changes were inconsistent without clear trend. For tumors with diffusivity above 1.0 μm 2 /ms, with prolonged echo time, there was a pronounced ADC increase of up to 12%. Meanwhile, for tumors with diffusivity at or below 1.0 μm 2 /ms, no change or a reduction was observed. Similar results were observed for gradient performance reduction, with an increase of up to 21%. The coefficient of variation determined in repeat experiments was 2.4%.

CONCLUSIONS: For PGSE and the explored parameter range, normal tissue ADC changes seem negligible. Meanwhile, observed tumor ADC changes can be relevant if ADC is used as a quantitative biomarker and not merely assessed by visual inspection. This highlights the importance of reporting all pertinent timing parameters in ADC studies and of considering these effects when building scan protocols for use in multicenter investigations.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Johansson J, Lagerstrand K, Björkman-Burtscher IM, et al. Normal Brain and Brain Tumor ADC: Changes Resulting From Variation of Diffusion Time and/or Echo Time in Pulsed-Gradient Spin Echo Diffusion Imaging. Invest Radiol. 2024. PMID: 38587357. doi:10.1097/RLI.0000000000001081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。